title: A successful treatment strategy for clozapine-induced parotid swelling: a clinical case and systematic review.
abstract: Parotid gland swelling is a less frequently reported side effect of clozapine and has no licensed treatment. A 58-year-old man treated with clozapine for treatment-resistant schizophrenia developed bilateral painful parotid swellings and hypersalivation. Initial trials of dose alteration and antihypersalivatory medication had limited success. A combination of benzatropine and terazosin was successful in treating the parotid hyperplasia. Clozapine was the probable cause of parotid swelling in our case, as established using the Naranjo adverse drug reaction probability scale and World Health Organization causality categories. Literature for treatments of clozapine-induced parotid gland swellings was reviewed. None of the published articles suggested a treatment regimen for clozapine-induced parotid hyperplasia. Most reports only highlighted the occurrence of salivary gland swelling with clozapine. Others mentioned management strategies, which included spontaneous resolution, or resolution on discontinuing clozapine. One report, a trial with benzatropine and ipratropium, had variable success. In this case the re-emergence of parotid swelling when terazosin and benzatropine doses were missed followed by a quick resolution upon recompliance, goes some way in proving that this combination is indeed effective. The combination of terazosin and benzatropine appears to have a role in treating parotid gland swellings induced by clozapine.
authors: Bristol Specialist Drug and Alcohol Service, The Blackberry Centre, Blackberry Hill Hospital, Manor Road, Fishponds, Bristol, BS16 2EW, UK.
authors: Vyasa
authors: V
authors: Immadisetty
authors: Pradeep
authors: P
authors: Agrawal
keywords: Benzatropine; clozapine; parotid; swelling; terazosin
references: Schizophr Bull. 1991;17(2):247-61
references: 1882209
references: Cochrane Database Syst Rev. 2000;(2):CD000059
references: 10796289
references: Psychopharmacology (Berl). 1989;99 Suppl:S105-8
references: 2813663
references: J Psychopharmacol. 2011 May;25(5):567-620
references: 21292923
references: Am J Psychiatry. 1996 Mar;153(3):445
references: 8610845
references: Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005579
references: 18646130
references: Curr Med Chem. 2004 Feb;11(3):279-96
references: 14965232
references: Clin Pharmacol Ther. 1981 Aug;30(2):239-45
references: 7249508
references: Schizophr Bull. 1998;24(3):381-90
references: 9718630
references: Am J Psychiatry. 1992 Sep;149(9):1183-8
references: 1503130
references: Mayo Clin Proc. 1998 Jun;73(6):590-6
references: 9621869
references: J Clin Psychopharmacol. 1996 Dec;16(6):462-3
references: 8959476
references: Biol Psychiatry. 1996 Jun 1;39(11):946-9
references: 9162206
references: Ann Pharmacother. 2000 May;34(5):662-5
references: 10852096
references: Am J Psychiatry. 1995 Feb;152(2):297-8
references: 7840372
references: Pharmacotherapy. 2000 Sep;20(9):1092-5
references: 10999502